Unknown

Dataset Information

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.


ABSTRACT:

Background

The main protease (Mpro) of SARS-CoV-2 is involved in the processing of vital polypeptides required for viral genome replication and transcription and is one of the best-characterized targets to inhibit the progression of SARS-CoV-2 in infected individuals.

Methods

We screened a set of novel classes of acridinediones molecules to efficiently bind and inhibit the activity of the SARS-CoV-2 by targeting the Mpro. The repurposed FDA-approved antivirals were taken as standard molecules for this study. Long term (1.1 μs) MD simulations were performed to analyze the conformational space of the binding pocket of Mpro bound to the selected molecules.

Results

The molecules DSPD-2 and DSPD-6 showed more favorable MM-PBSA interaction energies and were seated more deep

SUBMITTER: Bhardwaj VK 

PROVIDER: S-EPMC7659809 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature